{"Contradict fact": "The claim that France and South Korea have approved the use of hydroxychloroquine for COVID-19 contradicts the fact that France had actually revoked approval for the prescription of hydroxychloroquine as a COVID-19 treatment in May.", "Exaggerate": "The claim exaggerates the situation by stating that \"800 hospitals have commenced using it\" without providing enough evidence or support for this claim.", "Understate": "The claim understates the fact that France had banned the prescription of hydroxychloroquine the month before the claim was made, suggesting that the approval was recent when it was not.", "Lack enough support": "The claim lacks enough support or evidence to back up the statement that France and South Korea have approved the use of hydroxychloroquine for COVID-19.", "Problematic assumption": "The claim assumes that the approval of hydroxychloroquine in France and South Korea validates the effectiveness of the drug for COVID-19 treatment, without considering the potential side effects or other factors.", "Exist alternative explanation": "The claim fails to consider alternative explanations for the approval of hydroxychloroquine, such as political or economic factors, rather than solely relying on its effectiveness as a treatment for COVID-19."}